Melatonin and Melatonergic Influence on Neuronal Transcription Factors: Implications for the Development of Novel Therapies for Neurodegenerative Disorders

Dorsey, E.R.; Sherer, T.; Okun, M.S.; Bloem, B.R. The emerging evidence of the parkinson pandemic. J. Parkinsons Dis., 2018, 8(s1), S3-S8.
[http://dx.doi.org/10.3233/JPD-181474] [PMID: 30584159]

Wyss-Coray, T. Ageing, neurodegeneration and brain rejuvenation. Nature, 2016, 539(7628), 180-186.
[http://dx.doi.org/10.1038/nature20411] [PMID: 27830812]

Reitz, C.; Brayne, C.; Mayeux, R. Epidemiology of Alzheimer disease. Nat. Rev. Neurol., 2011, 7(3), 137-152.
[http://dx.doi.org/10.1038/nrneurol.2011.2] [PMID: 21304480]

Li, M.D.; Burns, T.C.; Morgan, A.A.; Khatri, P. Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases. Acta Neuropathol. Commun., 2014, 2, 93.
[http://dx.doi.org/10.1186/s40478-014-0093-y] [PMID: 21304480]

Reeve, A.; Simcox, E.; Turnbull, D. Ageing and Parkinson’s disease: why is advancing age the biggest risk factor? Ageing Res. Rev., 2014, 14, 19-30.
[http://dx.doi.org/10.1016/j.arr.2014.01.004] [PMID: 24503004]

Bae, B.I.; Jayaraman, D.; Walsh, C.A. Genetic changes shaping the human brain. Dev. Cell, 2015, 32(4), 423-434.
[http://dx.doi.org/10.1016/j.devcel.2015.01.035] [PMID: 25710529]

Cooper-Knock, J.; Kirby, J.; Ferraiuolo, L.; Heath, P.R.; Rattray, M.; Shaw, P.J. Gene expression profiling in human neurodegenerative disease. Nat. Rev. Neurol., 2012, 8(9), 518-530.
[http://dx.doi.org/10.1038/nrneurol.2012.156] [PMID: 22890216]

Ramanan, V.K.; Saykin, A.J. Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer’s disease, Parkinson’s disease, and related disorders. Am. J. Neurodegener. Dis., 2013, 2(3), 145-175.
[PMID: 24093081]

Kang, S.S.; Ebbert, M.T.W.; Baker, K.E.; Cook, C.; Wang, X.; Sens, J.P.; Kocher, J.P.; Petrucelli, L.; Fryer, J.D. Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau. J. Exp. Med., 2018, 215(9), 2235-2245.
[http://dx.doi.org/10.1084/jem.20180653] [PMID: 30082275]

Cenini, G.; Lloret, A.; Cascella, R. Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view. Oxid. Med. Cell. Longev., 2019, 20192105607
[http://dx.doi.org/10.1155/2019/2105607] [PMID: 31210837]

Singh, A.; Kukreti, R.; Saso, L.; Kukreti, S. Oxidative Stress: A key modulator in neurodegenerative diseases. Molecules, 2019, 24(8)E1583
[http://dx.doi.org/10.3390/molecules24081583] [PMID: 31013638]

Sweeney, M.D.; Kisler, K.; Montagne, A.; Toga, A.W.; Zlokovic, B.V. The role of brain vasculature in neurodegenerative disorders. Nat. Neurosci., 2018, 21(10), 1318-1331.
[http://dx.doi.org/10.1038/s41593-018-0234-x] [PMID: 30250261]

Cruz-Haces, M.; Tang, J.; Acosta, G.; Fernandez, J.; Shi, R. Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases. Transl. Neurodegener., 2017, 6, 20.
[http://dx.doi.org/10.1186/s40035-017-0088-2] [PMID: 28702179]

Wong, E.; Cuervo, A.M. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci., 2010, 13(7), 805-811.
[http://dx.doi.org/10.1038/nn.2575] [PMID: 20581817]

Chen, H.; Chan, D.C. Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases. Hum. Mol. Genet., 2009, 18(R2), R169-R176.
[http://dx.doi.org/10.1093/hmg/ddp326] [PMID: 19808793]

Lagier-Tourenne, C.; Polymenidou, M.; Cleveland, D.W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet., 2010, 19(R1), R46-R64.
[http://dx.doi.org/10.1093/hmg/ddq137] [PMID: 20400460]

Zheng, Q.; Huang, T.; Zhang, L.; Zhou, Y.; Luo, H.; Xu, H.; Wang, X. Dysregulation of ubiquitin-proteasome system in neurodegenerative diseases. Front. Aging Neurosci., 2016, 8, 303.
[http://dx.doi.org/10.3389/fnagi.2016.00303] [PMID: 28018215]

Eckert, D.; Buhl, S.; Weber, S.; Jäger, R.; Schorle, H. The AP-2 family of transcription factors. Genome Biol., 2005, 6(13), 246.
[http://dx.doi.org/10.1186/gb-2005-6-13-246] [PMID: 16420676]

Li, X.; Chen, X.; Zhou, W.; Ji, S.; Li, X.; Li, G.; Liu, G.; Wang, F.; Hao, A. Effect of melatonin on neuronal differentiation requires CBP/p300-mediated acetylation of histone H3 lysine 14. Neuroscience, 2017, 364, 45-59.
[http://dx.doi.org/10.1016/j.neuroscience.2017.07.064] [PMID: 28782640]

Mateus-Pinheiro, A.; Alves, N.D.; Patrício, P.; Machado-Santos, A.R.; Loureiro-Campos, E.; Silva, J.M.; Sardinha, V.M.; Reis, J.; Schorle, H.; Oliveira, J.F.; Ninkovic, J.; Sousa, N.; Pinto, L. AP2γ controls adult hippocampal neurogenesis and modulates cognitive, but not anxiety or depressive-like behavior. Mol. Psychiatry, 2017, 22(12), 1725-1734.
[http://dx.doi.org/10.1038/mp.2016.169] [PMID: 27777416]

Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4), 663-676.
[http://dx.doi.org/10.1016/j.cell.2006.07.024] [PMID: 16904174]

Yoo, Y.M.; Jung, E.M.; Choi, K.C.; Jeung, E.B. Effect of melatonin on mRNA expressions of transcription factors in murine embryonic stem cells. Brain Res., 2011, 1385, 1-7.
[http://dx.doi.org/10.1016/j.brainres.2011.02.047] [PMID: 21349252]

Calkhoven, C.F.; Ab, G. Multiple steps in the regulation of transcription-factor level and activity. Biochem. J., 1996, 317(Pt 2), 329-342.
[http://dx.doi.org/10.1042/bj3170329] [PMID: 8713055]

Shimozaki, K. Sox2 transcription network acts as a molecular switch to regulate properties of neural stem cells. World J. Stem Cells, 2014, 6(4), 485-490.
[http://dx.doi.org/10.4252/wjsc.v6.i4.485] [PMID: 25258670]

Bondy, S.C.; Campbell, A. Mechanisms underlying tumor suppressive properties of melatonin. Int. J. Mol. Sci., 2018, 19(8)E2205
[http://dx.doi.org/10.3390/ijms19082205] [PMID: 30060531]

Maston, G.A.; Evans, S.K.; Green, M.R. Transcriptional regulatory elements in the human genome. Annu. Rev. Genomics Hum. Genet., 2006, 7, 29-59.
[http://dx.doi.org/10.1146/annurev.genom.7.080505.115623] [PMID: 16719718]

Narlikar, G.J.; Fan, H.Y.; Kingston, R.E. Cooperation between complexes that regulate chromatin structure and transcription. Cell, 2002, 108(4), 475-487.
[http://dx.doi.org/10.1016/S0092-8674(02)00654-2] [PMID: 11909519]

Reiter, F.; Wienerroither, S.; Stark, A. Combinatorial function of transcription factors and cofactors. Curr. Opin. Genet. Dev., 2017, 43, 73-81.
[http://dx.doi.org/10.1016/j.gde.2016.12.007] [PMID: 28110180]

Barrow, J.J.; Masannat, J.; Bungert, J. Neutralizing the function of a β-globin-associated cis-regulatory DNA element using an artificial zinc finger DNA-binding domain. Proc. Natl. Acad. Sci. USA, 2012, 109(44), 17948-17953.
[http://dx.doi.org/10.1073/pnas.1207677109] [PMID: 23074246]

Labadorf, A.; Choi, S.H.; Myers, R.H. Evidence for a pan-neurodegenerative disease response in Huntington’s and Parkinson’s Disease expression profiles. Front. Mol. Neurosci., 2018, 10, 430.
[http://dx.doi.org/10.3389/fnmol.2017.00430] [PMID: 29375298]

Saxena, S.; Caroni, P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron, 2011, 71(1), 35-48.
[http://dx.doi.org/10.1016/j.neuron.2011.06.031] [PMID: 21745636]

Zhang, X.; Huai, J.; Shang, F.; Xu, G.; Tang, W.; Jing, Y.; Lin, R.A. PIF1/PIF3-HY5-BBX23 transcription factor cascade affects photomorphogenesis. Plant Physiol., 2017, 174(4), 2487-2500.
[http://dx.doi.org/10.1104/pp.17.00418] [PMID: 28687557]

Seberg, H.E.; Van Otterloo, E.; Cornell, R.A. Beyond MITF: Multiple transcription factors directly regulate the cellular phenotype in melanocytes and melanoma. Pigment Cell Melanoma Res., 2017, 30(5), 454-466.
[http://dx.doi.org/10.1111/pcmr.12611] [PMID: 28649789]

Grah, R.; Friedlander, T. The relation between crosstalk and gene regulation form revisited. PLOS Comput. Biol., 2020, 16(2) e1007642

Meunier, D.; Lambiotte, R.; Bullmore, E.T. Modular and hierarchically modular organization of brain networks. Front. Neurosci., 2010, 4, 200.
[http://dx.doi.org/10.3389/fnins.2010.00200] [PMID: 21151783 ]

Hecker, N.; Seemann, S.E.; Silahtaroglu, A.; Ruzzo, W.L.; Gorodkin, J. Associating transcription factors and conserved RNA structures with gene regulation in the human brain. Sci. Rep., 2017, 7(1), 5776.
[http://dx.doi.org/10.1038/s41598-017-06200-4] [PMID: 28720872 ]

Colantuoni, C.; Lipska, B.K.; Ye, T.; Hyde, T.M.; Tao, R.; Leek, J.T.; Colantuoni, E.A.; Elkahloun, A.G.; Herman, M.M.; Weinberger, D.R.; Kleinman, J.E. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature, 2011, 478(7370), 519-523.
[http://dx.doi.org/10.1038/nature10524] [PMID: 22031444 ]

Kang, H.J.; Kawasawa, Y.I.; Cheng, F.; Zhu, Y.; Xu, X.; Li, M.; Sousa, A.M.; Pletikos, M.; Meyer, K.A.; Sedmak, G.; Guennel, T.; Shin, Y.; Johnson, M.B.; Krsnik, Z.; Mayer, S.; Fertuzinhos, S.; Umlauf, S.; Lisgo, S.N.; Vortmeyer, A.; Weinberger, D.R.; Mane, S.; Hyde, T.M.; Huttner, A.; Reimers, M.; Kleinman, J.E.; Sestan, N. Spatio-temporal transcriptome of the human brain. Nature, 2011, 478(7370), 483-489.
[http://dx.doi.org/10.1038/nature10523] [PMID: 22031440 ]

Krauss, S.; Johansen, T.; Korzh, V.; Fjose, A. Expression pattern of zebrafish pax genes suggests a role in early brain regionalization. Nature, 1991, 353(6341), 267-270.
[http://dx.doi.org/10.1038/353267a0] [PMID: 1680220 ]

Martínez, S. The isthmic organizer and brain regionalization. Int. J. Dev. Biol., 2001, 45(1), 367-371.
[PMID: 11291867 ]

Sandberg, R.; Yasuda, R.; Pankratz, D.G.; Carter, T.A.; Del Rio, J.A.; Wodicka, L.; Mayford, M.; Lockhart, D.J.; Barlow, C. Regional and strain-specific gene expression mapping in the adult mouse brain. Proc. Natl. Acad. Sci. USA, 2000, 97(20), 11038-11043.
[http://dx.doi.org/10.1073/pnas.97.20.11038] [PMID: 11005875 ]

Datson, N.A.; van der Perk, J.; de Kloet, E.R.; Vreugdenhil, E. Expression profile of 30,000 genes in rat hippocampus using SAGE. Hippocampus, 2001, 11(4), 430-444.
[http://dx.doi.org/10.1002/hipo.1058] [PMID: 11530848 ]

Ertekin-Taner, N. Genetics of Alzheimer disease in the pre- and post-GWAS era. Alzheimers Res. Ther., 2010, 2(1), 3.
[http://dx.doi.org/10.1186/alzrt26] [PMID: 20236449 ]

Al-Chalabi, A.; Jones, A.; Troakes, C.; King, A.; Al-Sarraj, S.; van den Berg, L.H. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol., 2012, 124(3), 339-352.
[http://dx.doi.org/10.1007/s00401-012-1022-4] [PMID: 22903397 ]

Hooten, K.G.; Beers, D.R.; Zhao, W.; Appel, S.H. Protective and toxic neuroinflammation in amyotrophic lateral sclerosis. Neurotherapeutics, 2015, 12(2), 364-375.
[http://dx.doi.org/10.1007/s13311-014-0329-3] [PMID: 25567201 ]

Zufiría, M.; Gil-Bea, F.J.; Fernández-Torrón, R.; Poza, J.J.; Muñoz-Blanco, J.L.; Rojas-García, R.; Riancho, J.; López de Munain, A. ALS: A bucket of genes, environment, metabolism and unknown ingredients. Prog. Neurobiol., 2016, 142, 104-129.
[http://dx.doi.org/10.1016/j.pneurobio.2016.05.004] [PMID: 27236050 ]

García, J.C.; Bustos, R.H. The genetic diagnosis of neurodegenerative diseases and therapeutic perspectives. Brain Sci., 2018, 8(12)E222
[http://dx.doi.org/10.3390/brainsci8120222] [PMID: 30551598 ]

Billingsley, K.J.; Bandres-Ciga, S.; Saez-Atienzar, S.; Singleton, A.B. Genetic risk factors in Parkinson’s disease. Cell Tissue Res., 2018, 373(1), 9-20.
[http://dx.doi.org/10.1007/s00441-018-2817-y] [PMID: 29536161 ]

Pihlstrøm, L.; Wiethoff, S.; Houlden, H. Genetics of neurodegenerative diseases: an overview. Handb. Clin. Neurol., 2017, 145, 309-323.
[http://dx.doi.org/10.1016/B978-0-12-802395-2.00022-5] [PMID: 28987179 ]

Ryan, K.J.; White, C.C.; Patel, K.; Xu, J.; Olah, M.; Replogle, J.M.; Frangieh, M.; Cimpean, M.; Winn, P.; McHenry, A.; Kaskow, B.J.; Chan, G.; Cuerdon, N.; Bennett, D.A.; Boyd, J.D.; Imitola, J.; Elyaman, W.; De Jager, P.L.; Bradshaw, E.M. A human microglia-like cellular model for assessing the effects of neurodegenerative disease gene variants. Sci. Transl. Med., 2017, 9(421), 7635.
[http://dx.doi.org/10.1126/scitranslmed.aai7635] [PMID: 29263232 ]

Liu, G.; Sun, J.Y.; Xu, M.; Yang, X.Y.; Sun, B.L. SORL1 variants show different association with early-onset and late-onset alzheimer’s disease risk. J. Alzheimers Dis., 2017, 58(4), 1121-1128.
[http://dx.doi.org/10.3233/JAD-170005] [PMID: 28527213 ]

Sun, J.Y.; Hou, Y.J.; Zhang, Y.; Wang, L.; Liu, L.; Sun, B.L.; Yuan, H. genetic variants associated with neurodegenerative diseases regulate gene expression in immune cell cd14+ monocytes. Front. Genet., 2018, 9, 666.
[http://dx.doi.org/10.3389/fgene.2018.00666] [PMID: 30619483 ]

Jun, G.R.; Chung, J.; Mez, J.; Barber, R.; Beecham, G.W.; Bennett, D.A.; Buxbaum, J.D.; Byrd, G.S.; Carrasquillo, M.M.; Crane, P.K.; Cruchaga, C.; De Jager, P.; Ertekin-Taner, N.; Evans, D.; Fallin, M.D.; Foroud, T.M.; Friedland, R.P.; Goate, A.M.; Graff-Radford, N.R.; Hendrie, H.; Hall, K.S.; Hamilton-Nelson, K.L.; Inzelberg, R.; Kamboh, M.I.; Kauwe, J.S.K.; Kukull, W.A.; Kunkle, B.W.; Kuwano, R.; Larson, E.B.; Logue, M.W.; Manly, J.J.; Martin, E.R.; Montine, T.J.; Mukherjee, S.; Naj, A.; Reiman, E.M.; Reitz, C.; Sherva, R.; St George-Hyslop, P.H.; Thornton, T.; Younkin, S.G.; Vardarajan, B.N.; Wang, L.S.; Wendlund, J.R.; Winslow, A.R.; Haines, J.; Mayeux, R.; Pericak-Vance, M.A.; Schellenberg, G.; Lunetta, K.L.; Farrer, L.A. Transethnic genome-wide scan identifies novel Alzheimer’s disease loci. Alzheimers Dement., 2017, 13(7), 727-738.
[http://dx.doi.org/10.1016/j.jalz.2016.12.012] [PMID: 28183528 ]

Lambert, J.C.; Ibrahim-Verbaas, C.A.; Harold, D.; Naj, A.C.; Sims, R.; Bellenguez, C.; DeStafano, A.L.; Bis, J.C.; Beecham, G.W.; Grenier-Boley, B.; Russo, G.; Thorton-Wells, T.A.; Jones, N.; Smith, A.V.; Chouraki, V.; Thomas, C.; Ikram, M.A.; Zelenika, D.; Vardarajan, B.N.; Kamatani, Y.; Lin, C.F.; Gerrish, A.; Schmidt, H.; Kunkle, B.; Dunstan, M.L.; Ruiz, A.; Bihoreau, M.T.; Choi, S.H.; Reitz, C.; Pasquier, F.; Cruchaga, C.; Craig, D.; Amin, N.; Berr, C.; Lopez, O.L.; De Jager, P.L.; Deramecourt, V.; Johnston, J.A.; Evans, D.; Lovestone, S.; Letenneur, L.; Morón, F.J.; Rubinsztein, D.C.; Eiriksdottir, G.; Sleegers, K.; Goate, A.M.; Fiévet, N.; Huentelman, M.W.; Gill, M.; Brown, K.; Kamboh, M.I.; Keller, L.; Barberger-Gateau, P.; McGuiness, B.; Larson, E.B.; Green, R.; Myers, A.J.; Dufouil, C.; Todd, S.; Wallon, D.; Love, S.; Rogaeva, E.; Gallacher, J.; St George-Hyslop, P.; Clarimon, J.; Lleo, A.; Bayer, A.; Tsuang, D.W.; Yu, L.; Tsolaki, M.; Bossù, P.; Spalletta, G.; Proitsi, P.; Collinge, J.; Sorbi, S.; Sanchez-Garcia, F.; Fox, N.C.; Hardy, J.; Deniz Naranjo, M.C.; Bosco, P.; Clarke, R.; Brayne, C.; Galimberti, D.; Mancuso, M.; Matthews, F.; Moebus, S.; Mecocci, P.; Del Zompo, M.; Maier, W.; Hampel, H.; Pilotto, A.; Bullido, M.; Panza, F.; Caffarra, P.; Nacmias, B.; Gilbert, J.R.; Mayhaus, M.; Lannefelt, L.; Hakonarson, H.; Pichler, S.; Carrasquillo, M.M.; Ingelsson, M.; Beekly, D.; Alvarez, V.; Zou, F.; Valladares, O.; Younkin, S.G.; Coto, E.; Hamilton-Nelson, K.L.; Gu, W.; Razquin, C.; Pastor, P.; Mateo, I.; Owen, M.J.; Faber, K.M.; Jonsson, P.V.; Combarros, O.; O’Donovan, M.C.; Cantwell, L.B.; Soininen, H.; Blacker, D.; Mead, S.; Mosley, T.H., Jr; Bennett, D.A.; Harris, T.B.; Fratiglioni, L.; Holmes, C.; de Bruijn, R.F.; Passmore, P.; Montine, T.J.; Bettens, K.; Rotter, J.I.; Brice, A.; Morgan, K.; Foroud, T.M.; Kukull, W.A.; Hannequin, D.; Powell, J.F.; Nalls, M.A.; Ritchie, K.; Lunetta, K.L.; Kauwe, J.S.; Boerwinkle, E.; Riemenschneider, M.; Boada, M.; Hiltuenen, M.; Martin, E.R.; Schmidt, R.; Rujescu, D.; Wang, L.S.; Dartigues, J.F.; Mayeux, R.; Tzourio, C.; Hofman, A.; Nöthen, M.M.; Graff, C.; Psaty, B.M.; Jones, L.; Haines, J.L.; Holmans, P.A.; Lathrop, M.; Pericak-Vance, M.A.; Launer, L.J.; Farrer, L.A.; van Duijn, C.M.; Van Broeckhoven, C.; Moskvina, V.; Seshadri, S.; Williams, J.; Schellenberg, G.D.; Amouyel, P. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet., 2013, 45(12), 1452-1458.
[http://dx.doi.org/10.1038/ng.2802] [PMID: 24162737 ]

Nalls, M.A.; Pankratz, N.; Lill, C.M.; Do, C.B.; Hernandez, D.G.; Saad, M.; DeStefano, A.L.; Kara, E.; Bras, J.; Sharma, M.; Schulte, C.; Keller, M.F.; Arepalli, S.; Letson, C.; Edsall, C.; Stefansson, H.; Liu, X.; Pliner, H.; Lee, J.H.; Cheng, R.; Ikram, M.A.; Ioannidis, J.P.; Hadjigeorgiou, G.M.; Bis, J.C.; Martinez, M.; Perlmutter, J.S.; Goate, A.; Marder, K.; Fiske, B.; Sutherland, M.; Xiromerisiou, G.; Myers, R.H.; Clark, L.N.; Stefansson, K.; Hardy, J.A.; Heutink, P.; Chen, H.; Wood, N.W.; Houlden, H.; Payami, H.; Brice, A.; Scott, W.K.; Gasser, T.; Bertram, L.; Eriksson, N.; Foroud, T.; Singleton, A.B. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat. Genet., 2014, 46(9), 989-993.
[http://dx.doi.org/10.1038/ng.3043] [PMID: 25064009 ]

Chang, D.; Nalls, M.A.; Hallgrímsdóttir, I.B.; Hunkapiller, J.; van der Brug, M.; Cai, F.; Kerchner, G.A.; Ayalon, G.; Bingol, B.; Sheng, M.; Hinds, D.; Behrens, T.W.; Singleton, A.B.; Bhangale, T.R.; Graham, R.R. A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci. Nat. Genet., 2017, 49(10), 1511-1516.
[http://dx.doi.org/10.1038/ng.3955] [PMID: 28892059 ]

Liu, G.; Jiang, Y.; Wang, P.; Feng, R.; Jiang, N.; Chen, X.; Song, H.; Chen, Z. Cell adhesion molecules contribute to Alzheimer’s disease: multiple pathway analyses of two genome-wide association studies. J. Neurochem., 2012, 120(1), 190-198.
[http://dx.doi.org/10.1111/j.1471-4159.2011.07547.x] [PMID: 22017384 ]

Liu, G.; Zhang, Y.; Wang, L.; Xu, J.; Chen, X.; Bao, Y.; Hu, Y.; Jin, S.; Tian, R.; Bai, W.; Zhou, W.; Wang, T.; Han, Z.; Zong, J.; Jiang, Q. Alzheimer’s Disease rs11767557 Variant regulates epha1 gene expression specifically in human whole blood. J. Alzheimers Dis., 2018, 61(3), 1077-1088.
[http://dx.doi.org/10.3233/JAD-170468] [PMID: 29332039 ]

Jiang, Q.; Jin, S.; Jiang, Y.; Liao, M.; Feng, R.; Zhang, L.; Liu, G.; Hao, J. Alzheimer’s Disease variants with the genome-wide significance are significantly enriched in immune pathways and active in immune cells. Mol. Neurobiol., 2017, 54(1), 594-600.
[http://dx.doi.org/10.1007/s12035-015-9670-8] [PMID: 26746668 ]

Beecham, A.H.; Patsopoulos, N.A.; Xifara, D.K.; Davis, M.F.; Kemppinen, A.; Cotsapas, C.; Shah, T.S.; Spencer, C.; Booth, D.; Goris, A.; Oturai, A.; Saarela, J.; Fontaine, B.; Hemmer, B.; Martin, C.; Zipp, F.; D’Alfonso, S.; Martinelli-Boneschi, F.; Taylor, B.; Harbo, H.F.; Kockum, I.; Hillert, J.; Olsson, T.; Ban, M.; Oksenberg, J.R.; Hintzen, R.; Barcellos, L.F.; Agliardi, C.; Alfredsson, L.; Alizadeh, M.; Anderson, C.; Andrews, R.; Søndergaard, H.B.; Baker, A.; Band, G.; Baranzini, S.E.; Barizzone, N.; Barrett, J.; Bellenguez, C.; Bergamaschi, L.; Bernardinelli, L.; Berthele, A.; Biberacher, V.; Binder, T.M.; Blackburn, H.; Bomfim, I.L.; Brambilla, P.; Broadley, S.; Brochet, B.; Brundin, L.; Buck, D.; Butzkueven, H.; Caillier, S.J.; Camu, W.; Carpentier, W.; Cavalla, P.; Celius, E.G.; Coman, I.; Comi, G.; Corrado, L.; Cosemans, L.; Cournu-Rebeix, I.; Cree, B.A.; Cusi, D.; Damotte, V.; Defer, G.; Delgado, S.R.; Deloukas, P.; di Sapio, A.; Dilthey, A.T.; Donnelly, P.; Dubois, B.; Duddy, M.; Edkins, S.; Elovaara, I.; Esposito, F.; Evangelou, N.; Fiddes, B.; Field, J.; Franke, A.; Freeman, C.; Frohlich, I.Y.; Galimberti, D.; Gieger, C.; Gourraud, P.A.; Graetz, C.; Graham, A.; Grummel, V.; Guaschino, C.; Hadjixenofontos, A.; Hakonarson, H.; Halfpenny, C.; Hall, G.; Hall, P.; Hamsten, A.; Harley, J.; Harrower, T.; Hawkins, C.; Hellenthal, G.; Hillier, C.; Hobart, J.; Hoshi, M.; Hunt, S.E.; Jagodic, M.; Jelčić, I.; Jochim, A.; Kendall, B.; Kermode, A.; Kilpatrick, T.; Koivisto, K.; Konidari, I.; Korn, T.; Kronsbein, H.; Langford, C.; Larsson, M.; Lathrop, M.; Lebrun-Frenay, C.; Lechner-Scott, J.; Lee, M.H.; Leone, M.A.; Leppä, V.; Liberatore, G.; Lie, B.A.; Lill, C.M.; Lindén, M.; Link, J.; Luessi, F.; Lycke, J.; Macciardi, F.; Männistö, S.; Manrique, C.P.; Martin, R.; Martinelli, V.; Mason, D.; Mazibrada, G.; McCabe, C.; Mero, I.L.; Mescheriakova, J.; Moutsianas, L.; Myhr, K.M.; Nagels, G.; Nicholas, R.; Nilsson, P.; Piehl, F.; Pirinen, M.; Price, S.E.; Quach, H.; Reunanen, M.; Robberecht, W.; Robertson, N.P.; Rodegher, M.; Rog, D.; Salvetti, M.; Schnetz-Boutaud, N.C.; Sellebjerg, F.; Selter, R.C.; Schaefer, C.; Shaunak, S.; Shen, L.; Shields, S.; Siffrin, V.; Slee, M.; Sorensen, P.S.; Sorosina, M.; Sospedra, M.; Spurkland, A.; Strange, A.; Sundqvist, E.; Thijs, V.; Thorpe, J.; Ticca, A.; Tienari, P.; van Duijn, C.; Visser, E.M.; Vucic, S.; Westerlind, H.; Wiley, J.S.; Wilkins, A.; Wilson, J.F.; Winkelmann, J.; Zajicek, J.; Zindler, E.; Haines, J.L.; Pericak-Vance, M.A.; Ivinson, A.J.; Stewart, G.; Hafler, D.; Hauser, S.L.; Compston, A.; McVean, G.; De Jager, P.; Sawcer, S.J.; McCauley, J.L. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet., 2013, 45(11), 1353-1360.
[http://dx.doi.org/10.1038/ng.2770] [PMID: 24076602]

Liu, G.; Wang, T.; Tian, R.; Hu, Y.; Han, Z.; Wang, P.; Zhou, W.; Ren, P.; Zong, J.; Jin, S.; Jiang, Q. Alzheimer’s disease risk variant rs2373115 regulates GAB2 and NARS2 expression in human brain tissues. J. Mol. Neurosci., 2018, 66(1), 37-43.
[http://dx.doi.org/10.1007/s12031-018-1144-9] [PMID: 30088171 ]

Liu, G.; Zhang, F.; Hu, Y.; Jiang, Y.; Gong, Z.; Liu, S.; Chen, X.; Jiang, Q.; Hao, J. Genetic variants and multiple sclerosis risk gene SLC9A9 expression in distinct human brain regions. Mol. Neurobiol., 2017, 54(9), 6820-6826.
[http://dx.doi.org/10.1007/s12035-016-0208-5] [PMID: 27766536 ]

Cabantous, S.; Doumbo, O.; Poudiougou, B.; Louis, L.; Barry, A.; Oumar, A.A.; Traore, A.; Marquet, S.; Dessein, A. Gene expression analysis reveals genes common to cerebral malaria and neurodegenerative disorders. J. Infect. Dis., 2017, 216(6), 771-775.
[http://dx.doi.org/10.1093/infdis/jix359] [PMID: 28934429 ]

Arneson, D.; Zhang, Y.; Yang, X.; Narayanan, M. Shared mechanisms among neurodegenerative diseases: from genetic factors to gene networks. J. Genet., 2018, 97(3), 795-806.
[http://dx.doi.org/10.1007/s12041-018-0963-3] [PMID: 30027910 ]

Courtney, E.; Kornfeld, S.; Janitz, K.; Janitz, M. Transcriptome profiling in neurodegenerative disease. J. Neurosci. Methods, 2010, 193(2), 189-202.
[http://dx.doi.org/10.1016/j.jneumeth.2010.08.018] [PMID: 20800617 ]

Kim, J; Selvaraji, S; Kang, SW; Lee, WT; Chen, CL Choi H, Koo EH, Jo DG, Leong Lim K, Lim YA, Arumugam TV. Cerebral transcriptome analysis reveals age-dependent progression of neuroinflammation in P301S mutant tau transgenic male mice. Brain Behav Immun., 2019pii(S0889-1591(18)), , 30842-0.
[http://dx.doi.org/10.1016/j.bbi.2019.04.011]

van der Poel, M.; Ulas, T.; Mizee, M.R.; Hsiao, C.C.; Miedema, S.S.M. Adelia; Schuurman, K.G.; Helder, B.; Tas, S.W.; Schultze, J.L.; Hamann, J.; Huitinga, I. Transcriptional profiling of human microglia reveals grey-white matter heterogeneity and multiple sclerosis-associated changes. Nat. Commun., 2019, 10(1), 1139.
[http://dx.doi.org/10.1038/s41467-019-08976-7] [PMID: 30867424 ]

Grünblatt, E.; Zander, N.; Bartl, J.; Jie, L.; Monoranu, C.M.; Arzberger, T.; Ravid, R.; Roggendorf, W.; Gerlach, M.; Riederer, P. Comparison analysis of gene expression patterns between sporadic Alzheimer’s and Parkinson’s disease. J. Alzheimers Dis., 2007, 12(4), 291-311.
[http://dx.doi.org/10.3233/JAD-2007-12402] [PMID: 18198416 ]

Anderson, P.; Ivanov, P. tRNA fragments in human health and disease. FEBS Lett., 2014, 588(23), 4297-4304.
[http://dx.doi.org/10.1016/j.febslet.2014.09.001] [PMID: 25220675 ]

Liu, E.Y.; Cali, C.P.; Lee, E.B. RNA metabolism in neurodegenerative disease. Dis. Model. Mech., 2017, 10(5), 509-518.
[http://dx.doi.org/10.1242/dmm.028613] [PMID: 28468937 ]

Chu, C.T.; Plowey, E.D.; Wang, Y.; Patel, V.; Jordan-Sciutto, K.L. Location, location, location: altered transcription factor trafficking in neurodegeneration. J. Neuropathol. Exp. Neurol., 2007, 66(10), 873-883.
[http://dx.doi.org/10.1097/nen.0b013e318156a3d7] [PMID: 17917581 ]

Caldeira, G.L.; Ferreira, I.L.; Rego, A.C. Impaired transcription in Alzheimer’s disease: key role in mitochondrial dysfunction and oxidative stress. J. Alzheimers Dis., 2013, 34(1), 115-131.
[http://dx.doi.org/10.3233/JAD-121444] [PMID: 23364141 ]

Ciryam, P.; Kundra, R.; Freer, R.; Morimoto, R.I.; Dobson, C.M.; Vendruscolo, M. A transcriptional signature of Alzheimer’s disease is associated with a metastable subproteome at risk for aggregation. Proc. Natl. Acad. Sci. USA, 2016, 113(17), 4753-4758.
[http://dx.doi.org/10.1073/pnas.1516604113] [PMID: 27071083 ]

Kundra, R.; Ciryam, P.; Morimoto, R.I.; Dobson, C.M.; Vendruscolo, M. Protein homeostasis of a metastable subproteome associated with Alzheimer’s disease. Proc. Natl. Acad. Sci. USA, 2017, 114(28), E5703-E5711.
[http://dx.doi.org/10.1073/pnas.1618417114] [PMID: 28652376 ]

Chong, J.A.; Tapia-Ramírez, J.; Kim, S.; Toledo-Aral, J.J.; Zheng, Y.; Boutros, M.C.; Altshuller, Y.M.; Frohman, M.A.; Kraner, S.D.; Mandel, G. REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell, 1995, 80(6), 949-957.
[http://dx.doi.org/10.1016/0092-8674(95)90298-8] [PMID: 7697725 ]

Hwang, J.Y.; Aromolaran, K.A.; Zukin, R.S. The emerging field of epigenetics in neurodegeneration and neuroprotection. Nat. Rev. Neurosci., 2017, 18(6), 347-361.
[http://dx.doi.org/10.1038/nrn.2017.46] [PMID: 28515491 ]

Hwang, J.Y.; Zukin, R.S. REST, a master transcriptional regulator in neurodegenerative disease. Curr. Opin. Neurobiol., 2018, 48, 193-200.
[http://dx.doi.org/10.1016/j.conb.2017.12.008] [PMID: 29351877 ]

Zuccato, C.; Tartari, M.; Crotti, A.; Goffredo, D.; Valenza, M.; Conti, L.; Cataudella, T.; Leavitt, B.R.; Hayden, M.R.; Timmusk, T.; Rigamonti, D.; Cattaneo, E. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet., 2003, 35(1), 76-83.
[http://dx.doi.org/10.1038/ng1219] [PMID: 12881722 ]

Lu, T.; Aron, L.; Zullo, J.; Pan, Y.; Kim, H.; Chen, Y.; Yang, T.H.; Kim, H.M.; Drake, D.; Liu, X.S.; Bennett, D.A.; Colaiácovo, M.P.; Yankner, B.A. REST and stress resistance in ageing and Alzheimer’s disease. Nature, 2014, 507(7493), 448-454.
[http://dx.doi.org/10.1038/nature13163] [PMID: 24670762 ]

Cookson, M.R. Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways. Cold Spring Harb. Perspect. Med., 2012, 2(9) a009415
[http://dx.doi.org/10.1101/cshperspect.a009415] [PMID: 22951446 ]

Zhang, C.W.; Hang, L.; Yao, T.P.; Lim, K.L. parkin regulation and neurodegenerative disorders. Front. Aging Neurosci., 2016, 7, 248.
[http://dx.doi.org/10.3389/fnagi.2015.00248] [PMID: 26793099 ]

Unschuld, P.G.; Dächsel, J.; Darios, F.; Kohlmann, A.; Casademunt, E.; Lehmann-Horn, K.; Dichgans, M.; Ruberg, M.; Brice, A.; Gasser, T.; Lücking, C.B. Parkin modulates gene expression in control and ceramide-treated PC12 cells. Mol. Biol. Rep., 2006, 33(1), 13-32.
[http://dx.doi.org/10.1007/s11033-005-3961-5] [PMID: 16636914 ]

da Costa, C.A.; Sunyach, C.; Giaime, E.; West, A.; Corti, O.; Brice, A.; Safe, S.; Abou-Sleiman, P.M.; Wood, N.W.; Takahashi, H.; Goldberg, M.S.; Shen, J.; Checler, F. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson’s disease. Nat. Cell Biol., 2009, 11(11), 1370-1375.
[http://dx.doi.org/10.1038/ncb1981] [PMID: 19801972 ]

Vargas, D.M.; De Bastiani, M.A.; Zimmer, E.R.; Klamt, F. Alzheimer’s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates. Alzheimers Res. Ther., 2018, 10(1), 59.
[http://dx.doi.org/10.1186/s13195-018-0394-7] [PMID: 29935546 ]

Duplan, E.; Sevalle, J.; Viotti, J.; Goiran, T.; Bauer, C.; Renbaum, P.; Levy-Lahad, E.; Gautier, C.A.; Corti, O.; Leroudier, N.; Checler, F.; da Costa, C.A. Parkin differently regulates presenilin-1 and presenilin-2 functions by direct control of their promoter transcription. J. Mol. Cell Biol., 2013, 5(2), 132-142.
[http://dx.doi.org/10.1093/jmcb/mjt003] [PMID: 23359614 ]

Watson, G.; Ronai, Z.A.; Lau, E. ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease. Pharmacol. Res., 2017, 119, 347-357.
[http://dx.doi.org/10.1016/j.phrs.2017.02.004] [PMID: 28212892 ]

Boissière, F.; Hunot, S.; Faucheux, B.; Duyckaerts, C.; Hauw, J.J.; Agid, Y.; Hirsch, E.C. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer’s disease. Neuroreport, 1997, 8(13), 2849-2852.
[http://dx.doi.org/10.1097/00001756-199709080-00009] [PMID: 9376517 ]

McEachern, G.; Kassovska-Bratinova, S.; Raha, S.; Tarnopolsky, M.A.; Turnbull, J.; Bourgeois, J.; Robinson, B. Manganese superoxide dismutase levels are elevated in a proportion of amyotrophic lateral sclerosis patient cell lines. Biochem. Biophys. Res. Commun., 2000, 273(1), 359-363.
[http://dx.doi.org/10.1006/bbrc.2000.2933] [PMID: 10873611 ]

Kaltschmidt, B.; Widera, D.; Kaltschmidt, C. Signaling via NF-kappaB in the nervous system. Biochim. Biophys. Acta, 2005, 1745(3), 287-299.
[http://dx.doi.org/10.1016/j.bbamcr.2005.05.009] [PMID: 15993497 ]

Kitamura, Y.; Shimohama, S.; Ota, T.; Matsuoka, Y.; Nomura, Y.; Taniguchi, T. Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer’s disease brains. Neurosci. Lett., 1997, 237(1), 17-20.
[http://dx.doi.org/10.1016/S0304-3940(97)00797-0] [PMID: 9406869]

Shahni, R.; Cale, C.M.; Anderson, G.; Osellame, L.D.; Hambleton, S.; Jacques, T.S.; Wedatilake, Y.; Taanman, J.W.; Chan, E.; Qasim, W.; Plagnol, V.; Chalasani, A.; Duchen, M.R.; Gilmour, K.C.; Rahman, S. Signal transducer and activator of transcription 2 deficiency is a novel disorder of mitochondrial fission. Brain, 2015, 138(Pt 10), 2834-2846.
[http://dx.doi.org/10.1093/brain/awv182] [PMID: 26122121 ]

Motohashi, H.; Yamamoto, M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med., 2004, 10(11), 549-557.
[http://dx.doi.org/10.1016/j.molmed.2004.09.003] [PMID: 15519281 ]

Ramsey, C.P.; Glass, C.A.; Montgomery, M.B.; Lindl, K.A.; Ritson, G.P.; Chia, L.A.; Hamilton, R.L.; Chu, C.T.; Jordan-Sciutto, K.L. Expression of Nrf2 in neurodegenerative diseases. J. Neuropathol. Exp. Neurol., 2007, 66(1), 75-85.
[http://dx.doi.org/10.1097/nen.0b013e31802d6da9] [PMID: 17204939 ]

Theendakara, V.; Bredesen, D.E.; Rao, R.V. Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer’s disease. Mol. Cell. Neurosci., 2017, 83, 83-91.
[http://dx.doi.org/10.1016/j.mcn.2017.07.002] [PMID: 28720530 ]

Theendakara, V.; Peters-Libeu, C.A.; Spilman, P.; Poksay, K.S.; Bredesen, D.E.; Rao, R.V. Direct transcriptional effects of apolipoprotein E. J. Neurosci., 2016, 36(3), 685-700.
[http://dx.doi.org/10.1523/JNEUROSCI.3562-15.2016] [PMID: 26791201 ]

Culmsee, C.; Mattson, M.P. p53 in neuronal apoptosis. Biochem. Biophys. Res. Commun., 2005, 331(3), 761-777.
[http://dx.doi.org/10.1016/j.bbrc.2005.03.149] [PMID: 15865932 ]

de la Monte, S.M.; Sohn, Y.K.; Ganju, N.; Wands, J.R. P53- and CD95-associated apoptosis in neurodegenerative diseases. Lab. Invest., 1998, 78(4), 401-411.
[PMID: 9564885 ]

Morrison, R.S.; Kinoshita, Y.; Johnson, M.D.; Guo, W.; Garden, G.A. p53-dependent cell death signaling in neurons. Neurochem. Res., 2003, 28(1), 15-27.
[http://dx.doi.org/10.1023/A:1021687810103] [PMID: 12587660]

Filtz, T.M.; Vogel, W.K.; Leid, M. Regulation of transcription factor activity by interconnected post-translational modifications. Trends Pharmacol. Sci., 2014, 35(2), 76-85.
[http://dx.doi.org/10.1016/j.tips.2013.11.005] [PMID: 24388790 ]

Everett, L.; Hansen, M.; Hannenhalli, S. Regulating the regulators: modulators of transcription factor activity. Methods Mol. Biol., 2010, 674, 297-312.
[http://dx.doi.org/10.1007/978-1-60761-854-6_19] [PMID: 20827600 ]

Whitmarsh, A.J.; Davis, R.J. Regulation of transcription factor function by phosphorylation. Cell. Mol. Life Sci., 2000, 57(8-9), 1172-1183.
[http://dx.doi.org/10.1007/PL00000757] [PMID: 11028910 ]

Conaway, R.C.; Brower, C.S.; Conaway, J.W. Emerging roles of ubiquitin in transcription regulation. Science, 2002, 296(5571), 1254-1258.
[http://dx.doi.org/10.1126/science.1067466] [PMID: 12016299 ]

Geiss-Friedlander, R.; Melchior, F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol., 2007, 8(12), 947-956.
[http://dx.doi.org/10.1038/nrm2293] [PMID: 18000527 ]

Hart, G.W.; Slawson, C.; Ramirez-Correa, G.; Lagerlof, O. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu. Rev. Biochem., 2011, 80, 825-858.
[http://dx.doi.org/10.1146/annurev-biochem-060608-102511] [PMID: 21391816 ]

Akhtar, R.A.; Reddy, A.B.; Maywood, E.S.; Clayton, J.D.; King, V.M.; Smith, A.G.; Gant, T.W.; Hastings, M.H.; Kyriacou, C.P. Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr. Biol., 2002, 12(7), 540-550.
[http://dx.doi.org/10.1016/S0960-9822(02)00759-5] [PMID: 11937022 ]

Kim, M-Y.; Bae, J-S.; Kim, T-H.; Park, J-M.; Ahn, Y.H. Role of transcription factor modifications in the pathogenesis of insulin resistance. Exp. Diabetes Res., 2012, 20127, 16425.
[http://dx.doi.org/10.1155/2012/716425] [PMID: 22110478 ]

Berson, A.; Nativio, R.; Berger, S.L.; Bonini, N.M. Epigenetic regulation in neurodegenerative diseases. Trends Neurosci., 2018, 41(9), 587-598.
[http://dx.doi.org/10.1016/j.tins.2018.05.005] [PMID: 29885742]

Panda, S.; Antoch, M.P.; Miller, B.H.; Su, A.I.; Schook, A.B.; Straume, M.; Schultz, P.G.; Kay, S.A.; Takahashi, J.S.; Hogenesch, J.B. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell, 2002, 109(3), 307-320.
[http://dx.doi.org/10.1016/S0092-8674(02)00722-5] [PMID: 12015981]

Ross, A.W.; Barrett, P.; Mercer, J.G.; Morgan, P.J. Melatonin suppresses the induction of AP-1 transcription factor components in the pars tuberalis of the pituitary. Mol. Cell. Endocrinol., 1996, 123(1), 71-80.
[http://dx.doi.org/10.1016/0303-7207(96)03897-X] [PMID: 8912813 ]

Bondy, S.C.; Li, H.; Zhou, J.; Wu, M.; Bailey, J.A.; Lahiri, D.K. Melatonin alters age-related changes in transcription factors and kinase activation. Neurochem. Res., 2010, 35(12), 2035-2042.
[http://dx.doi.org/10.1007/s11064-010-0206-3] [PMID: 20535557 ]

Kang, J.W.; Hong, J.M.; Lee, S.M. Melatonin enhances mitophagy and mitochondrial biogenesis in rats with carbon tetrachloride-induced liver fibrosis. J. Pineal Res., 2016, 60(4), 383-393.
[http://dx.doi.org/10.1111/jpi.12319] [PMID: 26882442 ]

Onaolapo, A.Y.; Onaolapo, O.J. Brain and Behaviour, Gokare A. Ravishankar, Akula Ramakrishna (eds), In book: Serotonin and Melatonin: Their functional role in plants and implication in human health. CRC Press. ISBN 9781498739054 , 2015.

Onaolapo, O.J.; Onaolapo, A.Y. Melatonin receptors, behaviour and brain function. Lore Correia and Germaine Mayers (eds), In book: Melatonin: medical uses and role in health and disease, Chapter 4, pp 132-148, Publisher: Nova Science Publishers ISBN: 978-1-53612-987-8 , 2018.

Srinivasan, V. Melatonin oxidative stress and neurodegenerative diseases. Indian J. Exp. Biol., 2002, 40(6), 668-679.
[PMID: 12587715 ]

Olakowska, E.; Marcol, W.; Kotulska, K.; Lewin-Kowalik, J. The role of melatonin in the neurodegenerative diseases. Bratisl. Lek Listy, 2005, 106(4-5), 171-174.
[PMID: 16080363 ]

Srinivasan, V.; Pandi-Perumal, S.R.; Maestroni, G.J.; Esquifino, A.I.; Hardeland, R.; Cardinali, D.P. Role of melatonin in neurodegenerative diseases. Neurotox. Res., 2005, 7(4), 293-318.
[http://dx.doi.org/10.1007/BF03033887] [PMID: 16179266 ]

Wu, Y.H.; Feenstra, M.G.; Zhou, J.N.; Liu, R.Y.; Toranõ, J.S.; Van Kan, H.J.; Fischer, D.F.; Ravid, R.; Swaab, D.F. Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J. Clin. Endocrinol. Metab., 2003, 88(12), 5898-5906.
[http://dx.doi.org/10.1210/jc.2003-030833] [PMID: 14671188 ]

Zhou, J.N.; Liu, R.Y.; Kamphorst, W.; Hofman, M.A.; Swaab, D.F. Early neuropathological Alzheimer’s changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J. Pineal Res., 2003, 35(2), 125-130.
[http://dx.doi.org/10.1034/j.1600-079X.2003.00065.x] [PMID: 12887656 ]

Lin, L.; Huang, Q.X.; Yang, S.S.; Chu, J.; Wang, J.Z.; Tian, Q. Melatonin in Alzheimer’s disease. Int. J. Mol. Sci., 2013, 14(7), 14575-14593.
[http://dx.doi.org/10.3390/ijms140714575] [PMID: 23857055 ]

Onaolapo, O.J.; Onaolapo, A.Y.; Abiola, A.A.; Lillian, E.A. Central depressant and nootropic effects of daytime melatonin in mice. Ann. Neurosci., 2014, 21(3), 90-96.
[http://dx.doi.org/10.5214/ans.0972.7531.210304] [PMID: 25206072]

Onaolapo, A.Y.; Adebayo, A.N.; Onaolapo, O.J. Exogenous daytime melatonin modulates response of adolescent mice in a repeated unpredictable stress paradigm. Naunyn Schmiedebergs Arch. Pharmacol., 2017, 390(2), 149-161.
[http://dx.doi.org/10.1007/s00210-016-1314-7] [PMID: 27844092 ]

Onaolapo, O.J.; Onaolapo, A.Y. Melatonin and major neurocognitive disorders: beyond the management of sleep and circadian rhythm dysfunction. Sleep Hypn., 2018, 21, 73-96.
[http://dx.doi.org/10.5350/Sleep.Hypn.2019.21.0175]

Onaolapo, O.J.; Onaolapo, A.Y. Melatonin in drug addiction and addiction management: Exploring an evolving multidimensional relationship. World J. Psychiatry, 2018, 8(2), 64-74.
[http://dx.doi.org/10.5498/wjp.v8.i2.64] [PMID: 29988891 ]

Onaolapo, A.Y.; Onaolapo, O.J. Circadian dysrhythmia-linked diabetes mellitus: Examining melatonin’s roles in prophylaxis and management. World J. Diabetes, 2018, 9(7), 99-114.
[http://dx.doi.org/10.4239/wjd.v9.i7.99] [PMID: 30079146 ]

Onaolapo, A.Y.; Onaolapo, O.J.; Nathaniel, T.I. Cerebrovascular disease in the young adult: examining melatonin’s possible multiple roles. J. Exp. Neurosci., 2019, 131179069519827300
[http://dx.doi.org/10.1177/1179069519827300] [PMID: 30783379 ]

Onaolapo, A.Y.; Aina, O.A.; Onaolapo, O.J. Melatonin attenuates behavioural deficits and reduces brain oxidative stress in a rodent model of schizophrenia. Biomed. Pharmacother., 2017, 92, 373-383.
[http://dx.doi.org/10.1016/j.biopha.2017.05.094] [PMID: 28554133 ]

Onaolapo, O.J.; Onaolapo, A.Y. Melatonin, adolescence, and the brain: an insight into the period-specific influences of a multifunctional signalling molecule. Birth Defects Res., 2017, 109(20), 1659-1671.
[http://dx.doi.org/10.1002/bdr2.1171]

Bahna, S.G.; Niles, L.P. Epigenetic regulation of melatonin receptors in neuropsychiatric disorders. Br. J. Pharmacol., 2018, 175(16), 3209-3219.
[http://dx.doi.org/10.1111/bph.14058] [PMID: 28967098 ]

Sotthibundhu, A.; Ekthuwapranee, K.; Govitrapong, P. Comparison of melatonin with growth factors in promoting precursor cells proliferation in adult mouse subventricular zone. EXCLI J., 2016, 15, 829-841.
[http://dx.doi.org/10.17179/excli2016-606] [PMID: 28275319 ]

Lin, M.T.; Beal, M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 2006, 443(7113), 787-795.
[http://dx.doi.org/10.1038/nature05292] [PMID: 17051205 ]

Johri, A.; Beal, M.F. Mitochondrial dysfunction in neurodegenerative diseases. J. Pharmacol. Exp. Ther., 2012, 342(3), 619-630.
[http://dx.doi.org/10.1124/jpet.112.192138] [PMID: 22700435 ]

Manczak, M.; Anekonda, T.S.; Henson, E.; Park, B.S.; Quinn, J.; Reddy, P.H. Mitochondria are a direct site of A beta accumulation in Alzheimer’s disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet., 2006, 15(9), 1437-1449.
[http://dx.doi.org/10.1093/hmg/ddl066] [PMID: 16551656 ]

Ekstrand, M.I.; Terzioglu, M.; Galter, D.; Zhu, S.; Hofstetter, C.; Lindqvist, E.; Thams, S.; Bergstrand, A.; Hansson, F.S.; Trifunovic, A.; Hoffer, B.; Cullheim, S.; Mohammed, A.H.; Olson, L.; Larsson, N.G. Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons. Proc. Natl. Acad. Sci. USA, 2007, 104(4), 1325-1330.
[http://dx.doi.org/10.1073/pnas.0605208103] [PMID: 17227870 ]

Reddy, P.H.; Beal, M.F. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer’s disease. Trends Mol. Med., 2008, 14(2), 45-53.
[http://dx.doi.org/10.1016/j.molmed.2007.12.002] [PMID: 18218341 ]

Reddy, P.H. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer’s disease. Exp. Neurol., 2009, 218(2), 286-292.
[http://dx.doi.org/10.1016/j.expneurol.2009.03.042] [PMID: 19358844 ]

Galter, D.; Pernold, K.; Yoshitake, T.; Lindqvist, E.; Hoffer, B.; Kehr, J.; Larsson, N.G.; Olson, L. MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson’s disease. Genes Brain Behav., 2010, 9(2), 173-181.
[http://dx.doi.org/10.1111/j.1601-183X.2009.00542.x] [PMID: 20002202 ]

Kim, J.; Moody, J.P.; Edgerly, C.K.; Bordiuk, O.L.; Cormier, K.; Smith, K.; Beal, M.F.; Ferrante, R.J. Mitochondrial loss, dysfunction and altered dynamics in Huntington’s disease. Hum. Mol. Genet., 2010, 19(20), 3919-3935.
[http://dx.doi.org/10.1093/hmg/ddq306] [PMID: 20660112 ]

Swerdlow, R.H.; Burns, J.M.; Khan, S.M. The Alzheimer’s disease mitochondrial cascade hypothesis. J. Alzheimers Dis., 2010, 20(Suppl. 2), S265-S279.
[http://dx.doi.org/10.3233/JAD-2010-100339] [PMID: 20442494 ]

Reddy, P.H.; Reddy, T.P.; Manczak, M.; Calkins, M.J.; Shirendeb, U.; Mao, P. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res. Brain Res. Rev., 2011, 67(1-2), 103-118.
[http://dx.doi.org/10.1016/j.brainresrev.2010.11.004] [PMID: 21145355 ]

De Vos, K.J.; Mórotz, G.M.; Stoica, R.; Tudor, E.L.; Lau, K.F.; Ackerley, S.; Warley, A.; Shaw, C.E.; Miller, C.C. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum. Mol. Genet., 2012, 21(6), 1299-1311.
[http://dx.doi.org/10.1093/hmg/ddr559] [PMID: 22131369 ]

Sheng, B.; Wang, X.; Su, B.; Lee, H.G.; Casadesus, G.; Perry, G.; Zhu, X. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease. J. Neurochem., 2012, 120(3), 419-429.
[http://dx.doi.org/10.1111/j.1471-4159.2011.07581.x] [PMID: 22077634 ]

Chen, H.; McCaffery, J.M.; Chan, D.C. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell, 2007, 130(3), 548-562.
[http://dx.doi.org/10.1016/j.cell.2007.06.026] [PMID: 17693261 ]

Reddy, P.H. Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer’s disease. CNS Spectr, 2009, 14(8)(Suppl. 7), , 8-13 b.
[http://dx.doi.org/10.1017/S1092852900024901] [PMID: 19890241 ]

Reiter, R.J.; Rosales-Corral, S.; Tan, D.X.; Jou, M.J.; Galano, A.; Xu, B. Melatonin as a mitochondria-targeted antioxidant: one of evolution’s best ideas. Cell. Mol. Life Sci., 2017, 74(21), 3863-3881.
[http://dx.doi.org/10.1007/s00018-017-2609-7] [PMID: 28864909 ]

Tan, D.X.; Reiter, R.J. Mitochondria: the birth place, the battle ground and the site of melatonin metabolism. Melatonin Res., 2019, 2, 44-66.
[http://dx.doi.org/10.32794/mr11250011]

Reiter, R.J.; Tan, D.X.; Rosales-Corral, S.; Galano, A.; Zhou, X.J.; Xu, B. Mitochondria: Central Organelles for Melatonin’s Antioxidant and Anti-Aging Actions. Molecules, 2018, 23(2)E509
[http://dx.doi.org/10.3390/molecules23020509] [PMID: 29495303 ]

Carlberg, C. Gene regulation by melatonin. Ann. N. Y. Acad. Sci., 2000, 917, 387-396.
[http://dx.doi.org/10.1111/j.1749-6632.2000.tb05403.x] [PMID: 11268365 ]

Wiesenberg, I.; Missbach, M.; Carlberg, C. The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor. Neurol. Neurosci., 1998, 12(2-3), 143-150.
[PMID: 12671309 ]

Swanson, D.J.; Steshina, E.Y.; Wakenight, P.; Aldinger, K.A.; Goldowitz, D.; Millen, K.J.; Chizhikov, V.V. Phenotypic and genetic analysis of the cerebellar mutant tmgc26, a new ENU-induced ROR-alpha allele. Eur. J. Neurosci., 2010, 32(5), 707-716.
[http://dx.doi.org/10.1111/j.1460-9568.2010.07330.x] [PMID: 20722722 ]

Hardeland, R. Melatonin and retinoid orphan receptors: Demand for new interpretations after their exclusion as nuclear melatonin receptors. Melatonin Res., 2018, 1, 78-93.
[http://dx.doi.org/10.32794/mr11250005]

Franco-Iborra, S.; Vila, M.; Perier, C. Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson’s Disease and Huntington’s Disease. Front. Neurosci., 2018, 12, 342.
[http://dx.doi.org/10.3389/fnins.2018.00342] [PMID: 29875626 ]

Niles, L.P.; Sathiyapalan, A.; Bahna, S.; Kang, N.H.; Pan, Y. Valproic acid up-regulates melatonin MT1 and MT2 receptors and neurotrophic factors CDNF and MANF in the rat brain. Int. J. Neuropsychopharmacol., 2012, 15(9), 1343-1350.
[http://dx.doi.org/10.1017/S1461145711001969] [PMID: 22243807 ]

Bahna, S.G.; Sathiyapalan, A.; Foster, J.A.; Niles, L.P. Regional upregulation of hippocampal melatonin MT2 receptors by valproic acid: therapeutic implications for Alzheimer’s disease. Neurosci. Lett., 2014, 576, 84-87.
[http://dx.doi.org/10.1016/j.neulet.2014.05.056] [PMID: 24909617 ]

Jun, Z.; Li, Z.; Fang, W.; Fengzhen, Y.; Puyuan, W.; Wenwen, L.; Zhi, S.; Bondy, S.C. Melatonin decreases levels of S100β and NFKB, increases levels of synaptophysin in a rat model of Alzheimer’s disease. Curr. Aging Sci., 2013, 6(2), 142-149.
[http://dx.doi.org/10.2174/18746098112059990005] [PMID: 23030129 ]

Ali, T.; Rehman, S.U.; Shah, F.A.; Kim, M.O. Acute dose of melatonin via Nrf2 dependently prevents acute ethanol-induced neurotoxicity in the developing rodent brain. J. Neuroinflammation, 2018, 15(1), 119.
[http://dx.doi.org/10.1186/s12974-018-1157-x] [PMID: 29679979 ]

Xu, W.; Lu, X.; Zheng, J.; Li, T.; Gao, L.; Lenahan, C.; Shao, A.; Zhang, J.; Yu, J. Melatonin protects against neuronal apoptosis via suppression of the ATF6/CHOP pathway in a rat model of intracerebral hemorrhage. Front. Neurosci., 2018, 12, 638.
[http://dx.doi.org/10.3389/fnins.2018.00638] [PMID: 30283292 ]

Zhao, Y.; Zhao, R.; Wu, J.; Wang, Q.; Pang, K.; Shi, Q.; Gao, Q.; Hu, Y.; Dong, X.; Zhang, J.; Sun, J. Melatonin protects against Aβ-induced neurotoxicity in primary neurons via miR-132/PTEN/AKT/FOXO3a pathway. Biofactors, 2018, 44(6), 609-618.
[http://dx.doi.org/10.1002/biof.1411] [PMID: 29322615 ]

Onphachanh, X.; Lee, H.J.; Lim, J.R.; Jung, Y.H.; Kim, J.S.; Chae, C.W.; Lee, S.J.; Gabr, A.A.; Han, H.J. Enhancement of high glucose-induced PINK1 expression by melatonin stimulates neuronal cell survival: Involvement of MT₂ /Akt/NF-κB pathway. J. Pineal Res., 2017, 63(2)
[http://dx.doi.org/10.1111/jpi.12427] [PMID: 28580603 ]

Deng, Y.; Zhu, J.; Mi, C.; Xu, B.; Jiao, C.; Li, Y.; Xu, D.; Liu, W.; Xu, Z. Melatonin antagonizes Mn-induced oxidative injury through the activation of keap1-Nrf2-ARE signaling pathway in the striatum of mice. Neurotox. Res., 2015, 27(2), 156-171.
[http://dx.doi.org/10.1007/s12640-014-9489-5] [PMID: 25288107 ]

Song, J.; Kang, S.M.; Lee, K.M.; Lee, J.E. The protective effect of melatonin on neural stem cell against LPS-induced inflammation. BioMed Res. Int., 2015, 2015854359
[http://dx.doi.org/10.1155/2015/854359] [PMID: 25705693 ]

Zheng, B.; Hao, D.; Guo, H.; He, B. Melatonin alleviates acute spinal cord injury in rats through promoting on progenitor cells proliferation. Saudi Pharm. J., 2017, 25, 570-574.
[http://dx.doi.org/10.1016/j.jsps.2017.04.025]

Beni, S.M.; Kohen, R.; Reiter, R.J.; Tan, D.X.; Shohami, E. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J., 2004, 18(1), 149-151.
[http://dx.doi.org/10.1096/fj.03-0323fje] [PMID: 14597558 ]

Li, Z.; Li, X.; Bi, J.; Chan, M.T.V.; Wu, W.K.K.; Shen, J. Melatonin protected against the detrimental effects of microRNA-363 in a rat model of vitamin A-associated congenital spinal deformities: Involvement of Notch signaling. J. Pineal Res., 2019, 66(3)e12558
[http://dx.doi.org/10.1111/jpi.12558] [PMID: 30653707 ]

Sajjad, M.U.; Samson, B.; Wyttenbach, A. Heat shock proteins: therapeutic drug targets for chronic neurodegeneration? Curr. Pharm. Biotechnol., 2010, 11(2), 198-215.
[http://dx.doi.org/10.2174/138920110790909641] [PMID: 20166961 ]

Neef, D.W.; Jaeger, A.M.; Thiele, D.J. Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nat. Rev. Drug Discov., 2011, 10(12), 930-944.
[http://dx.doi.org/10.1038/nrd3453] [PMID: 22129991 ]

Mielcarek, M.; Zielonka, D.; Carnemolla, A.; Marcinkowski, J.T.; Guidez, F. HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements. Front. Cell. Neurosci., 2015, 9, 42.
[http://dx.doi.org/10.3389/fncel.2015.00042] [PMID: 25759639 ]

Cardinali, D.P.; Vigo, D.E.; Olivar, N.; Vidal, M.F.; Brusco, L.I. Melatonin therapy in patients with Alzheimer’s Disease. Antioxidants (Basel), 2014, 10(3(2)), 245-77.
[http://dx.doi.org/10.3390/antiox3020245]

O’Neal-Moffitt, G.; Delic, V.; Bradshaw, P.C.; Olcese, J. Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice. Mol. Neurodegener., 2015, 10, 27.
[http://dx.doi.org/10.1186/s13024-015-0027-6] [PMID: 26159703 ]

Arushanian, E.B. A hormonal drug melatonin in the treatment of cognitive function disorders in parkinsonism. Eksp. Klin. Farmakol., 2010, 73(3), 35-39.
[PMID: 20408429 ]

Litvinenko, I.V.; Krasakov, I.V.; Tikhomirova, O.V. Sleep disorders in Parkinson’s disease without dementia: a comparative randomized controlled study of melatonin and clonazepam. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova, 2012, 112(12), 26-30.
[PMID: 23388588 ]

Datieva, V.K.; Rosinskaia, A.V.; Levin, O.S. The use of melatonin in the treatment of chronic fatigue syndrome and circadian rhythm disorders in Parkinson’s disease. Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova, 2013, 113(7 Pt 2), 77-81.
[PMID: 23994935 ]

Zhang, Y.; Cook, A.; Kim, J.; Baranov, S.V.; Jiang, J.; Smith, K.; Cormier, K.; Bennett, E.; Browser, R.P.; Day, A.L.; Carlisle, D.L.; Ferrante, R.J.; Wang, X.; Friedlander, R.M. Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis., 2013, 55, 26-35.
[http://dx.doi.org/10.1016/j.nbd.2013.03.008] [PMID: 23537713 ]

Asayama, K.; Yamadera, H.; Ito, T.; Suzuki, H.; Kudo, Y.; Endo, S. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J. Nippon Med. Sch., 2003, 70(4), 334-341.
[http://dx.doi.org/10.1272/jnms.70.334] [PMID: 12928714 ]

Riemersma-van der Lek, R.F.; Swaab, D.F.; Twisk, J.; Hol, E.M.; Hoogendijk, W.J.; Van Someren, E.J. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA, 2008, 299(22), 2642-2655.
[http://dx.doi.org/10.1001/jama.299.22.2642] [PMID: 18544724 ]

de Jonghe, A.; Korevaar, J.C.; van Munster, B.C.; de Rooij, S.E. Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review. Int. J. Geriatr. Psychiatry, 2010, 25(12), 1201-1208.
[http://dx.doi.org/10.1002/gps.2454] [PMID: 21086534 ]

Cardinali, D.P.; Vigo, D.E.; Olivar, N.; Vidal, M.F.; Furio, A.M.; Brusco, L.I. Therapeutic application of melatonin in mild cognitive impairment. Am. J. Neurodegener. Dis., 2012, 1(3), 280-291.
[PMID: 23383398 ]